Research Article

Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study

Table 1

Characteristics of patients with MPMs.

PatientSex Year of kidney transplant Patient’s age at transplantImmunosuppressive drugs usedAcute rejection eventsType of first tumorDate of first tumorType of second tumorDate of second tumorReturn to dialysis (year)Status
(last follow-up)

1M199539CCS + CyA + MycNoBCC2001Melanoma2006No Alive (2012)
2M198725CCS + CyANoSCC2008SCC2008Yes (2010)Alive (2012)
3M200164CCS + CyA + MycNoBCC2006SCC2006Yes (2011)Alive (2012)
4M200362CCS + FK > 
> Rap + CCS
NoProstate Ca2010Kidney Ca2010No Alive (2012)
5M200155CCS + CyA + MycNoBCC2002SCC2002NoAlive (2010)
6M198845CyA > Rap + CCSNoKaposi2004Gastric MALToma2005Yes (2006)Dead (2006)
7M200155CCS + FK + MycNoBCC2003SCC2003No Alive (2012)
8M199242CCS + CyA No SCC2005BCC + SCC2005NoAlive (2012)
9M199739CyA + AzaNoSCC2003Melanoma2012No Alive (2012)
10M199551CCS + CyA + MycNoBCC2005BCC + SCC2010/2011No Alive (2012)
11F200453CCS + CyA >
> Rap + CCS
NoLung Ca2005SCC2006Yes (2007)Dead (2007)
12M199856CCS + CyA NoSCC1999BCC2007No Alive (2012)
13M199218CCS + CyA + MycYes BCC2000SCC2000Yes (2008)Alive (2012)
14M200161CCS + Rap + MycNoSCC2006SCC2007No Alive (2007)
15M198929CyA + Aza >
> Rap + CCS
NoBCC2007SCC2007No Alive (2012)
16M200543CCS + CyANoMelanoma 2008BCC2008No Alive (2012)
17M199959CCS + CyA + MycNoBCC2004SCC2004NoAlive (2011)
18M198646CCS + CyANoSCC1997Melanoma2004Yes (2004)Dead (2007)
19M200035CCS + CyA + MycNoSCC2006BCC2012NoAlive (2012)
20M199438CCS + CYANoSCC2000SCC2000Yes (2010)Alive (2012)
21F199956CCS + CYANoSCC2004BCC2004NoAlive (2012)
22F199649FK + Aza >
> FK
NoBCC2001BCC2001No Alive (2012)
23F198756CCS + FKNoBCC1998SCC2006Yes (2011)Alive (2012)
24M200560CCS + FK >
> Rap > FK
NoSCC2006Colon Ca2011Yes (2012)Alive (2012)

M: male; F: female.
CCS: corticosteroids; Aza: azathioprine; CyA: cyclosporine; FK: tacrolimus; Myc: mycophenolate and derivatives; Rap: rapamycin and derivatives.
>: switch to other drug(s).
Ca: carcinoma; SCC: squamous cell carcinoma; BCC: basal cell carcinoma; Kaposi: Kaposi sarcoma; MALToma: neoplasm of mucosa associated lymphoid tissue.